Anifrolumab for the treatment of refractory chilblain lupus erythematosus

• Michael J. Woodbury, BS,
• Katherine Nabel Smith, PhD,
• Jeffrey S. Smith, MD, PhD,
• Joseph F. Merola, MD, MMSc

Affiliations

Michael J. Woodbury, BS

Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas

Katherine Nabel Smith, PhD

Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas

Jeffrey S. Smith, MD, PhD

Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas

Joseph F. Merola, MD, MMSc

Correspondence to: Joseph F. Merola, MD, MMSc, Department of Dermatology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390.; Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas